Related Experiment Video
Updated: Jul 13, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
[Cardiac abnormalities in antiphospholipid syndrome]
Xiao-mei Meng1, Yan Zhao, Li-gang Fang
1Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Insights
Antiphospholipid syndrome (APS) frequently causes cardiac issues, including valve abnormalities and thrombosis. Anticoagulation therapy effectively prevented further thrombotic events in patients with cardiac involvement.
Area of Science:
- Rheumatology
- Cardiology
- Hematology
Context:
- Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent thrombosis and pregnancy morbidity.
- Cardiac involvement is a significant but often under-recognized complication of APS.
Purpose:
- To investigate the clinical manifestations, treatment, and prognosis of antiphospholipid syndrome (APS).
- To analyze the relationship between cardiac abnormalities and thrombotic events in APS patients.
Summary:
- A retrospective analysis of 72 APS patients revealed vascular thrombosis in 59.7% and cardiac abnormalities in 66.6%.
- Mitral valve involvement was common, and cardiac abnormalities were significantly associated with thrombosis and prolonged activated partial thromboplastin time (APTT).
- Anticoagulation therapy was effective in preventing recurrent thrombosis in APS patients with cardiac involvement.
Impact:
- Highlights the high prevalence of cardiac manifestations in APS.
- Underscores the link between hypercoagulability, cardiac involvement, and thrombotic events in APS.
- Provides evidence for the efficacy of anticoagulation in managing APS-related cardiac complications.
Objective:
To investigate the clinical manifestations, treatment and prognosis of antiphospholipid syndrome (APS).
Methods:
The cases of 72 patients with defined APS admitted from Jan 1990 to Jan 2006 were analyzed retrospectively.
Results:
21 patients with primary APS and 51 patients with secondary APS were studied. Vascular thrombosis was present in 43 (59.7%) of the 72 patients in this study. Cardiac abnormalities could be observed in 48 patients (66.6%). Lesions most frequently involved left-sided valves, mitral (35.4%) more commonly affected than aortic (16.7%). Cardiac involvement was significantly related to thrombosis (P = 0.007) and prolonged activated partial thromboplastin time (APTT) (P = 0.026). Valvular involvement was significantly related to brain infarcts (P = 0.008) and thrombosis (P = 0.029). 20 APS patients with cardiac abnormalities and thrombosis received anticoagulation therapy and thrombosis did not happen any more during follow-up.
Conclusion:
Cardiac manifestations of APS are valve abnormalities (valve thickening and vegetations), occlusive arterial disease (atherosclerosis and myocardial infarction), ventricular dysfunction and pulmonary hypertension. Cardiac abnormalities in APS are likely to be related to hypercoagulability.
Related Concept Videos
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Rheumatic Heart Disease I: Introduction